Heart Failure with Preserved Ejection Fraction (HFpEF) Latest Advances
Find the Latest Research About Heart Failure with Preserved Ejection Fraction (HFpEF)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11919 publications
Macrophage-Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction.
Journal: Journal of the American Heart Association
Published: June 23, 2026
Women in Heart Failure With Preserved Ejection Fraction Clinical Trials: Bridging the Gap Between Trial Enrollment and Real-World Disease Burden.
Journal: Cardiology in review
Published: June 23, 2026
Structural Cardiac Abnormalities, Ventricular Dysfunction Phenotypes, and Heart Failure Risk among Antiretroviral Therapy-treated People Living with HIV in South Africa.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
Soluble Urokinase Plasminogen Activator Receptor Primes Macrophages and Worsens Heart Failure with Preserved Ejection Fraction.
Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026
Pitfalls of therapies targeting the nitric oxide signaling pathway in heart failure with preserved ejection fraction.
Journal: Journal of cardiovascular pharmacology
Published: June 22, 2026
Phenotypic Characterization of Unclassified Pulmonary Hypertension.
Journal: Circulation. Heart failure
Published: June 19, 2026
Heart Failure with Preserved Ejection Fraction as a Syndrome of Reduced Effective Stroke Volume.
Journal: American journal of physiology. Heart and circulatory physiology
Published: June 19, 2026
Past, Present, and Future of Evaluating Diastolic Function.
Journal: Circulation. Cardiovascular imaging
Published: June 18, 2026
Aortic Stenosis and Heart Failure With Preserved Ejection Fraction: A Cautionary Tale of Common Partners.
Journal: Circulation. Heart failure
Published: June 17, 2026
Alterations in Cardiac and Systemic Metabolism in Heart Failure.
Journal: Circulation. Heart failure
Published: June 17, 2026
Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular Disease: Redefining Therapy Through Cardiometabolic Substrate Modification.
Journal: Cardiology in review
Published: June 17, 2026
Last Updated: 06/30/2026